Skip to main content
Log in

Leukocyte-depleted blood cardioplegia reduces cardiac troponin T release in patients undergoing coronary artery bypass grafting

  • Original Article
  • Published:
The Japanese Journal of Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objective: Activated neutrophils have been implicated in reperfusion injury of the myocardium. Leukocyte depletion at reperfusion may contribute to better myocardial protection during cardiac surgery. We tested the efficacy of leukocyte-depleted blood cardioplegia in reducing myocardial injury during coronary artery bypass grafting.Methods: Subjects were 27 patients undergoing elective coronary artery bypass grafting divided into controls (perfused with nonfiltered blood cardioplegia, n = 12) and those undergoing leukocyte-depleted blood cardioplegia (n = 15). Oxygenated blood mixed with a potassium crystalloid cardioplegic solution was delivered through the aortic root at every 30 minutes during cardiac arrest and terminal warm blood was administered before aortic declamping in both groups. In leukocyte depletion, blood was filtered prior to the mixture with crystalloid solution in the cardioplegic reservoir.Results: Patient profiles did not differ significantly between groups, nor did systemic leukocyte count during or after surgery despite more than 81% removal of leukocytes in cardioplegic delivery. No consistent differences between groups in creatine kinase or creatine kinase-MB were seen up to 18 hours after surgery. Peak troponin T levels were significantly lower in the leukocyte-depleted blood cardioplegia group (0.52±0.13 ng/ml), however, than in controls (3.85±0.85 ng/ml).Conclusion: We concluded that leukocyte-depleted blood cardioplegia reduces the release of cardiac troponin T in patients undergoing elective coronary artery bypass grafting and may produce better myocardial protection in patients with impaired cardiac function or a damaged myocardium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Engler RL, Schmid-Schonbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983; 111: 98–111.

    PubMed  CAS  Google Scholar 

  2. Suzuki M, Inauen W, Kvietys PR. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Am J Physiol 1989; 257: H1740–5.

    PubMed  CAS  Google Scholar 

  3. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–57.

    PubMed  CAS  Google Scholar 

  4. Fantone HC, Ward PA. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol 1982; 107: 397–418.

    CAS  Google Scholar 

  5. Becker LC, Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 1987; 30: 23–44.

    Article  PubMed  CAS  Google Scholar 

  6. Hearse DJ. Reperfusion of the ischemic myocardium. J Mol Cell Cardiol 1977; 9: 605–16.

    Article  PubMed  CAS  Google Scholar 

  7. Opie LH. Reperfusion injury and its pharmacologic modification. Circulation 1989; 80: 1049–62.

    Article  PubMed  CAS  Google Scholar 

  8. Vinten-Johansen J, Chiantella V, Faust KB. Myocardial protection with blood cardioplegia in ischemically injured hearts: reduction of reoxygenation injury with allopurinol. Ann Thorac Surg 1988; 45: 319–26.

    Article  PubMed  CAS  Google Scholar 

  9. Teoh KH, Christakis GT, Weisel RD. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg 1986; 91: 888–95.

    PubMed  CAS  Google Scholar 

  10. Buckberg GD, Beyersdorf F, Allen BS, Robertson JM. Integrated myocardial management: background and initial application. J Card Surg 1995; 10: 68–89.

    Article  PubMed  CAS  Google Scholar 

  11. William WG, Rebeyka IM, Tibshirani RJ, Coles JG, Lightfoot NE, Mehra A, et al. Warm induction blood cardioplegia in the infant. J Thorac Cardiovasc Surg 1990; 100: 896–901.

    Google Scholar 

  12. Pearl JM, Drinkwater DC, Laks H, Capouya ER, Gates RN. Leukocyte-depleted reperfusion of transplanted human hearts: a randomized, double-blind clinical trial. J Heart Lung Transplant 1992; 11: 1082–92.

    PubMed  CAS  Google Scholar 

  13. Pearl JM, Drinkwater DC, Laks H, Stein DG, Capouya ER, Bhuda S. Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res 1992; 52: 298–308.

    Article  PubMed  CAS  Google Scholar 

  14. Hachida M, Hanayama M, Maeda T, Shimabukuro T, Okamura T, Chikasawa G, et al. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. Jpn J Artif Organs 1996; 25: 785–8.

    Google Scholar 

  15. Breda MA, Drinkwater DC, Laks H. Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood. J Thorac Cardiovasc Surg 1989; 97: 654–65.

    PubMed  CAS  Google Scholar 

  16. Chung-Chun C, Matsuda H, Sawa Y. Effects of a cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury. Ann Thorac Surg 1991; 52: 495–99.

    Article  Google Scholar 

  17. Sawa Y, Matsuda H, Shimazaki Y, Kaneko M, Nishimura M, Amemiya A, et al. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994; 108: 1125–31.

    PubMed  CAS  Google Scholar 

  18. Ichimura T, Yasuura K, Abe T. The effects of a leukocyte removal filter during cold blood cardioplegia (Eng abstr). J Jpn Assn Thorac Surg 1994; 42: 531–36.

    Google Scholar 

  19. Go Lo, Murry CE, Richard VJ, Weischedel GR, Jennings RB, Reimer KA. Myocardial neutrophil accumulation during reperfusion after reversible and irreversible ischemic injury. Am J Physiol 1988; 255: H1188–98.

    PubMed  CAS  Google Scholar 

  20. Heggie AJ, Corder JC, Crichton PR, Hesford JW, Bingham H, Jefferies S, et al. Clinical evaluation of the new Pall leukocyte depleting blood cardioplegia filter (BC1). 20th Cong on Perfusion, Soc Perfusi of Great Britain and Ireland (abstract) 1994.

  21. Wu AHB, Valdes R Jr, Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, et al. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin Chem 1994; 40: 900–7.

    PubMed  CAS  Google Scholar 

  22. Gerhardt W, Katus HA, Ravkilde J, Hamm C, Jorgensen PJ, Peheim E, et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem 1991; 37: 1752–6.

    Google Scholar 

  23. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin T and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992; 38: 2203–14.

    PubMed  CAS  Google Scholar 

  24. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdahl L, et al. The prognostic value of serum troponin T in unstable angina. New Engl J Med 1992; 327: 146–50.

    Article  PubMed  CAS  Google Scholar 

  25. Gourlay T, Fleming J, Taylor KM. Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter. Perfusion 1992; 7: 131–40.

    Article  PubMed  CAS  Google Scholar 

  26. Palanzo DA, Manley NJ, Montesano RM, Yeisley GL, Gordon D. Clinical evaluation of the LeukoGuard (LG-6) arterial line filter for routine open-heart surgery. Perfusion 1993; 8: 489–96.

    Article  Google Scholar 

  27. Edmunds LH Jr. Why cardiopulmonary bypass makes patients sick?; strategies to control the blood synthetic surface interface. In: Karp RB, Laks H, Wechsler AS, eds. Advance in Cardiac Surgery Vol. 6, Chicago: Mosby-Year Book Inc., 1995: 131–67.

    Google Scholar 

  28. Hiramatsu Y, Gikakis N, Anderson HL III, Gorman JH III, Gould RJ, Niewiarowski S, Edmunds LH Jr, et al. Tirofiban provides “platelet anesthesia” during cardiopulmonary bypass in baboons. J Thorac Cardiovasc Surg 1997; 113: 182–93.

    Article  PubMed  CAS  Google Scholar 

  29. Gikakis N, Khan MMH, Hiramatsu Y, Gorman JH III, Hack CE, Sun L, et al. Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation. Circulation 1996; 94 (Suppl II): II–341-6.

    Google Scholar 

  30. Sundaram S, Gikakis N, Hack CE, Niewiarowski S, Edmunds LH Jr, Rao AK, et al. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation. Thromb Haemost 1996; 75: 76–82.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Read at the 6th Annual Meeting of The Asian Society for Cardiovascular Surgery, Tokyo, Japan, February 18–20, 1998.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hiramatsu, Y., Koishizawa, T., Matsuzaki, K. et al. Leukocyte-depleted blood cardioplegia reduces cardiac troponin T release in patients undergoing coronary artery bypass grafting. Jpn J Thorac Caridovasc Surg 48, 625–631 (2000). https://doi.org/10.1007/BF03218217

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03218217

Key words

Navigation